BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38118389)

  • 1. Association between intermittent hypoxemia and neurodevelopmental outcomes in extremely premature infants: A single-center experience.
    Kim F; Bateman DA; Garey D; Goldshtrom N; Isler JR; Sahni R; Wallman-Stokes A
    Early Hum Dev; 2024 Jan; 188():105919. PubMed ID: 38118389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
    Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Extremely Preterm Infants With Birth Weight Less Than 400 g.
    Brumbaugh JE; Hansen NI; Bell EF; Sridhar A; Carlo WA; Hintz SR; Vohr BR; Colaizy TT; Duncan AF; Wyckoff MH; Baack ML; Rysavy MA; DeMauro SB; Stoll BJ; Das A; Higgins RD;
    JAMA Pediatr; 2019 May; 173(5):434-445. PubMed ID: 30907941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Intermittent Hypoxemia or Bradycardia and Late Death or Disability in Extremely Preterm Infants.
    Poets CF; Roberts RS; Schmidt B; Whyte RK; Asztalos EV; Bader D; Bairam A; Moddemann D; Peliowski A; Rabi Y; Solimano A; Nelson H;
    JAMA; 2015 Aug; 314(6):595-603. PubMed ID: 26262797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of developmental outcomes in a very preterm Canadian cohort.
    Synnes A; Luu TM; Moddemann D; Church P; Lee D; Vincer M; Ballantyne M; Majnemer A; Creighton D; Yang J; Sauve R; Saigal S; Shah P; Lee SK;
    Arch Dis Child Fetal Neonatal Ed; 2017 May; 102(3):F235-F234. PubMed ID: 27758929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of maternal pre-pregnancy or first trimester body mass index with neurodevelopmental impairment or death in extremely low gestational age neonates.
    Chawla S; Laptook AR; Smith EA; Tan S; Natarajan G; Wyckoff MH; Greenberg RG; Ambalavanan N; Bell EF; Van Meurs KP; Hintz SR; Vohr BR; Werner EF; Das A; Shankaran S;
    J Perinatol; 2024 Jun; 44(6):802-810. PubMed ID: 38396053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection care bundle implementation is associated with improved long-term neurodevelopmental outcomes in extremely premature infants.
    Benlamri A; Murthy P; Zein H; Thomas S; Scott JN; Abou Mehrem A; Esser MJ; Lodha A; Noort J; Tang S; Metcalfe C; Kowal D; Irvine L; Scotland J; Leijser LM; Mohammad K
    J Perinatol; 2022 Oct; 42(10):1380-1384. PubMed ID: 35831577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of admission temperature and death or adverse neurodevelopmental outcomes in extremely low-gestational age neonates.
    Ting JY; Synnes AR; Lee SK; Shah PS;
    J Perinatol; 2018 Jul; 38(7):844-849. PubMed ID: 29795318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental and Behavioral Outcomes in Extremely Premature Neonates With Ventriculomegaly in the Absence of Periventricular-Intraventricular Hemorrhage.
    Pappas A; Adams-Chapman I; Shankaran S; McDonald SA; Stoll BJ; Laptook AR; Carlo WA; Van Meurs KP; Hintz SR; Carlson MD; Brumbaugh JE; Walsh MC; Wyckoff MH; Das A; Higgins RD;
    JAMA Pediatr; 2018 Jan; 172(1):32-42. PubMed ID: 29181530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayley-III scales at 12 months of corrected age in preterm infants: Patterns of developmental performance and correlations to environmental and biological influences.
    Velikos K; Soubasi V; Michalettou I; Sarafidis K; Nakas C; Papadopoulou V; Zafeiriou D; Drossou V
    Res Dev Disabil; 2015; 45-46():110-9. PubMed ID: 26232203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.
    Weisz DE; Mirea L; Rosenberg E; Jang M; Ly L; Church PT; Kelly E; Kim SJ; Jain A; McNamara PJ; Shah PS
    JAMA Pediatr; 2017 May; 171(5):443-449. PubMed ID: 28264088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
    Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
    Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Transport Risk Index of Physiologic Stability in Extremely Premature Infants and Mortality or Neurodevelopmental Impairment at 18 to 24 Months.
    Grass B; Ye XY; Kelly E; Synnes A; Lee S
    J Pediatr; 2020 Sep; 224():51-56.e5. PubMed ID: 32442448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year neurodevelopmental outcome in children born extremely preterm: the EPI-DAF study.
    van Beek PE; Rijken M; Broeders L; Ter Horst HJ; Koopman-Esseboom C; de Kort E; Laarman C; Mulder-de Tollenaer SM; Steiner K; Swarte RM; van Westering-Kroon E; Oei SG; Leemhuis AG; Andriessen P;
    Arch Dis Child Fetal Neonatal Ed; 2022 Sep; 107(5):467-474. PubMed ID: 35236745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental Outcomes after Bevacizumab Treatment for Retinopathy of Prematurity: A Meta-analysis.
    Tsai CY; Yeh PT; Tsao PN; Chung YE; Chang YS; Lai TT
    Ophthalmology; 2021 Jun; 128(6):877-888. PubMed ID: 33212122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental outcomes of premature infants with severe intraventricular hemorrhage.
    Calisici E; Eras Z; Oncel MY; Oguz SS; Gokce İK; Dilmen U
    J Matern Fetal Neonatal Med; 2015; 28(17):2115-20. PubMed ID: 25354288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal and Neurodevelopmental Outcomes Following Linezolid for Coagulase-negative Staphylococcal Infection: Real World Evidence.
    Sicard M; Moussa A; Barrington K; Martin B; Luu TM; Ting JY; Roberts A; Paquette V; Shah PS; Kelly E; Autmizguine J
    Pediatr Infect Dis J; 2020 Jul; 39(7):598-603. PubMed ID: 32091496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage.
    Payne AH; Hintz SR; Hibbs AM; Walsh MC; Vohr BR; Bann CM; Wilson-Costello DE;
    JAMA Pediatr; 2013 May; 167(5):451-9. PubMed ID: 23460139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines.
    Puia-Dumitrescu M; Comstock BA; Li S; Heagerty PJ; Perez KM; Law JB; Wood TR; Gogcu S; Mayock DE; Juul SE;
    JAMA Netw Open; 2021 Jul; 4(7):e2115998. PubMed ID: 34232302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.